Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)
Kinuko Hirose(University of Yamanashi), Kanji Sugita(University of Yamanashi), Yoshitaka Miyagawa(National Center For Child Health and Development), Berthold Göttgens(Wellcome/MRC Cambridge Stem Cell Institute), Toshiya Inaba(Hiroshima University), Hidemitsu Kurosawa(St. Jude Children's Research Hospital), Itaru Kuroda(University of Yamanashi), Takeshi Inukai(University of Yamanashi), Tomokatsu Ikawa(Tokyo University of Science), Yusuke Furukawa(Jichi Medical University), Hirotaka Matsui(Hiroshima University), Jiro Kikuchi(Jichi Medical University), Nobutaka Kiyokawa(National Center For Child Health and Development), Koshi Akahane(University of Yamanashi), S. Oram(University of Cambridge), A. Thomas Look(Dana-Farber Cancer Institute), Hajime Okita(Keio University), Xiaochun Zhang(Shanghai East Hospital), Keiko Kagami(University of Yamanashi), Hiroshi Kawamoto(Fujita Health University), Hiroko Honna(University of Yamanashi), Kumiko Goi(St. Jude Children's Research Hospital)
Cited by 39
Related Papers
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
|Cancer Cell|2002|1.1k
Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal
|Cell stem cell|2014|703
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
<i>FBW7</i> mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
|The Journal of Experimental Medicine|2007|660